What is Eusolex 232 used for?

Eusolex 232 is indicated for Sunscreen agent.

What development phase is Eusolex 232 in?

Eusolex 232 is FDA-approved (marketed).

What is the generic name of Eusolex 232?

ENSULIZOLE is the generic (nonproprietary) name of Eusolex 232.

Last reviewed 2026-04-20 · How we verify

Eusolex 232 (ENSULIZOLE)

FDA-approved active Small molecule Quality 10/100

Eusolex 232, also known as ENSULIZOLE, is a small molecule sunscreen agent. It is used to protect the skin from the sun's ultraviolet (UV) rays. The commercial status of Eusolex 232 is not specified, but it is used as an active ingredient in various sunscreen products. As a sunscreen agent, Eusolex 232 works by absorbing or reflecting UV radiation, preventing it from penetrating the skin and causing damage. It is not approved for any other medical indications.

At a glance

Generic name	ENSULIZOLE
Modality	Small molecule
Therapeutic area	Oncology
Phase	FDA-approved

Approved indications

Sunscreen agent

Common side effects

No common side effects on file.

Key clinical trials

Determination of Sun Protection in Sunscreen Formulas (Study SR09-15)(P08236)(COMPLETED) (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Eusolex 232 CI brief — competitive landscape report
Eusolex 232 updates RSS · CI watch RSS